AI begins to challenge the most complex systems: life

What happened: On October 17, Zheyuan Technology released the WHIRLPO computational medicine platform. The article frames AI life science as shifting from single molecule models toward "life world models" that simulate whole biological systems. Key numbers: Biohub's virtual biology initiative committed $500 million, later expanded Why it matters: The article argues AI drug discovery has produced limited clinical value, with few projects reaching Phase III, and that competition is moving from model benchmarks to infrastructure for data, multi-scale modeling, and closed-loop lab validation.

On October 17, Zheyuan Technology released the WHIRLPO computational medicine platform. The article frames AI life science as shifting from single molecule models toward "life world models" that simulate whole biological systems.

The article argues AI drug discovery has produced limited clinical value, with few projects reaching Phase III, and that competition is moving from model benchmarks to infrastructure for data, multi-scale modeling, and closed-loop lab validation.